EPCAM and cancer: Mechanistically, CD44v6 influenced the expression of key CSC markers, including CD24, CD133, and EpCAM, which are known to be associated with cancer progression, stemness, and malignant behaviors like self-renewal, proliferation, migration, and chemoresistance [10,30–34].